Effect of Anti-reflux Suture on Gastroesophageal Reflux Symptoms After One Anastomosis Gastric Bypass: a Randomized Controlled Trial
Overview
General Surgery
Radiology
Authors
Affiliations
Purpose: Gastroesophageal reflux disease (GERD) is an issue after one anastomosis gastric bypass (OAGB) and modification of OAGB with adding an anti-reflux system may decrease the incidence of postoperative GERD. This study aimed to compare the efficacy of the anti-reflux mechanism to treat preoperative GERD and prevent de novo GERD.
Methods: A prospective randomized clinical trial study was conducted on patients with a body mass index of 40 and more from August 2020 to February 2022. Patients undergoing one anastomosis gastric bypass with and without anti-reflux sutures (groups A and B, respectively). These patients had follow-ups for one year after the surgery. GERD symptoms were assessed in all the patients using the GERD symptom questionnaire.
Results: The mean age was 39.5 ± 9.8 years and 40.7 ± 10.2 years in groups A and B respectively. GERD symptoms remission occurred in 76.5% and 68.4% of patients in groups A and B, respectively. The incidence of de novo GERD symptoms was lower in group A, compared to group B (6.2% and 16.1% in groups A and B respectively), without any statistically significant difference (p-value: 0.239).
Conclusion: GERD symptoms and de novo GERD after OAGB seems to be under-reported after OAGB. This study suggests that applying an anti-reflux suture can decrease de novo GERD symptoms.
ElFawal M, Taha O, Abdelaal M, Mohamad D, El Haj I, Tamim H Obes Surg. 2025; .
PMID: 40087244 DOI: 10.1007/s11695-025-07700-3.
Felsenreich D, Vock N, Zach M, Kristo I, Jedamzik J, Bichler C Surg Endosc. 2025; .
PMID: 39966130 DOI: 10.1007/s00464-025-11606-7.
Mostafapour E, Shahsavan M, Shahmiri S, Jawhar N, Ghanem O, Kermansaravi M BMC Surg. 2024; 24(1):156.
PMID: 38755612 PMC: 11097460. DOI: 10.1186/s12893-024-02438-8.